{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:21:46Z","timestamp":1792783306873,"version":"4.5.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"KRESCENT program: Kidney Foundation of Canada","id":[{"id":"https:\/\/ror.org\/019a0gk53","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Canadian Institute of Health Research Early Career Researcher operating grant","id":[{"id":"https:\/\/ror.org\/01gavpb45","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00467-026-07280-z","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T14:27:59Z","timestamp":1775831279000},"page":"3011-3022","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Proteome-wide Mendelian randomization identifies APOM and TNXB as actionable mediators of steroid-sensitive nephrotic syndrome"],"prefix":"10.1007","volume":"41","author":[{"given":"Daniel","family":"Heydari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboobeh","family":"Norouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Myette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Butler-Laporte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallory L.","family":"Downie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"7280_CR1","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1080\/20469047.2017.1374003","volume":"37","author":"ML Downie","year":"2017","unstructured":"Downie ML, Gallibois C, Parekh RS, Noone DG (2017) Nephrotic syndrome in infants and children: pathophysiology and management. Paediatr Int Child Health 37:248\u2013258. https:\/\/doi.org\/10.1080\/20469047.2017.1374003","journal-title":"Paediatr Int Child Health"},{"key":"7280_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.26574\/maedica.2022.17.2.271","volume":"17","author":"L Popa","year":"2022","unstructured":"Popa L, Balgradean M, Croitoru A (2022) Long-term study in children with steroid-resistant nephrotic syndrome progressing to end-stage renal disease. Maedica (Bucur) 17:271\u2013276. https:\/\/doi.org\/10.26574\/maedica.2022.17.2.271","journal-title":"Maedica (Bucur)"},{"key":"7280_CR3","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1177\/87551225221116266","volume":"38","author":"EJ Koshi","year":"2022","unstructured":"Koshi EJ, Young K, Mostales JC et al (2022) Complications of corticosteroid therapy: a comprehensive literature review. J Pharm Technol 38:360\u2013367. https:\/\/doi.org\/10.1177\/87551225221116266","journal-title":"J Pharm Technol"},{"key":"7280_CR4","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1007\/s00467-021-05135-3","volume":"36","author":"R Ehren","year":"2021","unstructured":"Ehren R, Benz MR, Brinkk\u00f6tter PT et al (2021) Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy \u2014short version of the updated German best practice guideline (S2e) \u2014 AWMF register no. 166-001, 6\/2020. Pediatr Nephrol 36:2971\u20132985. https:\/\/doi.org\/10.1007\/s00467-021-05135-3","journal-title":"Pediatr Nephrol"},{"key":"7280_CR5","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/s41588-020-0682-6","volume":"52","author":"J Zheng","year":"2020","unstructured":"Zheng J, Haberland V, Baird D et al (2020) Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases. Nat Genet 52:1122\u20131131. https:\/\/doi.org\/10.1038\/s41588-020-0682-6","journal-title":"Nat Genet"},{"key":"7280_CR6","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41591-021-01281-1","volume":"27","author":"S Zhou","year":"2021","unstructured":"Zhou S, Butler-Laporte G, Nakanishi T et al (2021) A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity. Nat Med 27:659\u2013667. https:\/\/doi.org\/10.1038\/s41591-021-01281-1","journal-title":"Nat Med"},{"key":"7280_CR7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1681\/ASN.2021060794","volume":"33","author":"AJB Watts","year":"2022","unstructured":"Watts AJB, Keller KH, Lerner G et al (2022) Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology. J Am Soc Nephrol 33:238\u2013252. https:\/\/doi.org\/10.1681\/ASN.2021060794","journal-title":"J Am Soc Nephrol"},{"key":"7280_CR8","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.kint.2025.01.019","volume":"107","author":"FE Hengel","year":"2025","unstructured":"Hengel FE, Dehde S, Yilmaz A et al (2025) Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome may inform treatment strategy. Kidney Int 107:1099\u20131103. https:\/\/doi.org\/10.1016\/j.kint.2025.01.019","journal-title":"Kidney Int"},{"key":"7280_CR9","doi-asserted-by":"publisher","unstructured":"Al-Aubodah T-A, Leclerc S, Aoudjit L et al (2025) Autoantibodies targeting CRB2 and Nephrin correlate with extrafollicular B cells in idiopathic podocytopathies. bio. Rxiv. 9(6):674-608. https:\/\/doi.org\/10.1101\/2025.09.06.674608","DOI":"10.1101\/2025.09.06.674608"},{"key":"7280_CR10","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.kint.2024.09.006","volume":"106","author":"V Raglianti","year":"2024","unstructured":"Raglianti V, Angelotti ML, Cirillo L et al (2024) Anti-slit diaphragm antibodies on kidney biopsy identify pediatric patients with steroid-resistant nephrotic syndrome responsive to second-line immunosuppressants. Kidney Int 106:1124\u20131134. https:\/\/doi.org\/10.1016\/j.kint.2024.09.006","journal-title":"Kidney Int"},{"key":"7280_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62032-1","volume":"16","author":"S He","year":"2025","unstructured":"He S, Zhu C, Liu Y et al (2025) A longitudinal cohort study uncovers plasma protein biomarkers predating clinical onset and treatment response of rheumatoid arthritis. Nat Commun 16:6692. https:\/\/doi.org\/10.1038\/s41467-025-62032-1","journal-title":"Nat Commun"},{"key":"7280_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101093","volume":"4","author":"ES Nakayasu","year":"2023","unstructured":"Nakayasu ES, Bramer LM, Ansong C et al (2023) Plasma protein biomarkers predict the development of persistent autoantibodies and type 1 diabetes 6\u00a0months prior to the onset of autoimmunity. Cell Rep Med 4:101093. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101093","journal-title":"Cell Rep Med"},{"key":"7280_CR13","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41586-023-06388-8","volume":"620","author":"K Trajanoska","year":"2023","unstructured":"Trajanoska K, Bh\u00e9rer C, Taliun D et al (2023) From target discovery to clinical drug development with human genetics. Nature 620:737\u2013745. https:\/\/doi.org\/10.1038\/s41586-023-06388-8","journal-title":"Nature"},{"key":"7280_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/jmedgenet-2014-102438","volume":"52","author":"LE Mokry","year":"2015","unstructured":"Mokry LE, Ahmad O, Forgetta V et al (2015) Mendelian randomisation applied to drug development in cardiovascular disease: a review. J Med Genet 52:71\u201379. https:\/\/doi.org\/10.1136\/jmedgenet-2014-102438","journal-title":"J Med Genet"},{"key":"7280_CR15","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1056\/NEJMoa054013","volume":"354","author":"JC Cohen","year":"2006","unstructured":"Cohen JC, Boerwinkle E, Mosley TH, Hobbs HH (2006) Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 354:1264\u20131272. https:\/\/doi.org\/10.1056\/NEJMoa054013","journal-title":"N Engl J Med"},{"key":"7280_CR16","doi-asserted-by":"publisher","first-page":"e658","DOI":"10.1016\/S2665-9913(20)30345-3","volume":"2","author":"J Bovijn","year":"2020","unstructured":"Bovijn J, Lindgren CM, Holmes MV (2020) Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19. Lancet Rheumatol 2:e658\u2013e659. https:\/\/doi.org\/10.1016\/S2665-9913(20)30345-3","journal-title":"Lancet Rheumatol"},{"key":"7280_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-072087","volume":"13","author":"MK Sobczyk","year":"2023","unstructured":"Sobczyk MK, Zheng J, Davey Smith G, Gaunt TR (2023) Systematic comparison of Mendelian randomisation studies and randomised controlled trials using electronic databases. BMJ Open 13:e072087. https:\/\/doi.org\/10.1136\/bmjopen-2023-072087","journal-title":"BMJ Open"},{"key":"7280_CR18","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith G, Hemani G (2014) Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet 23:R89\u2013R98. https:\/\/doi.org\/10.1093\/hmg\/ddu328","journal-title":"Hum Mol Genet"},{"key":"7280_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2337\/dc21-1049","volume":"45","author":"N Yazdanpanah","year":"2022","unstructured":"Yazdanpanah N, Yazdanpanah M, Wang Y et al (2022) Clinically relevant circulating protein biomarkers for type 1 diabetes: evidence from a two-sample Mendelian randomization study. Diabetes Care 45:169\u2013177. https:\/\/doi.org\/10.2337\/dc21-1049","journal-title":"Diabetes Care"},{"key":"7280_CR20","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR et al (2021) Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement. JAMA 326:1614\u20131621. https:\/\/doi.org\/10.1001\/jama.2021.18236","journal-title":"JAMA"},{"key":"7280_CR21","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun BB, Chiou J, Traylor M et al (2023) Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622:329\u2013338. https:\/\/doi.org\/10.1038\/s41586-023-06592-6","journal-title":"Nature"},{"key":"7280_CR22","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad E, Sulem P, Atlason BA et al (2021) Large-scale integration of the plasma proteome with genetics and disease. Nat Genet 53:1712\u20131721. https:\/\/doi.org\/10.1038\/s41588-021-00978-w","journal-title":"Nat Genet"},{"key":"7280_CR23","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1126\/science.aaq1327","volume":"361","author":"V Emilsson","year":"2018","unstructured":"Emilsson V, Ilkov M, Lamb JR et al (2018) Co-regulatory networks of human serum proteins link genetics to disease. Science 361:769\u2013773. https:\/\/doi.org\/10.1126\/science.aaq1327","journal-title":"Science"},{"key":"7280_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj1541","volume":"374","author":"M Pietzner","year":"2021","unstructured":"Pietzner M, Wheeler E, Carrasco-Zanini J et al (2021) Mapping the proteo-genomic convergence of human diseases. Science 374:eabj1541. https:\/\/doi.org\/10.1126\/science.abj1541","journal-title":"Science"},{"key":"7280_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14357","volume":"8","author":"K Suhre","year":"2017","unstructured":"Suhre K, Arnold M, Bhagwat AM et al (2017) Connecting genetic risk to disease end points through the human blood plasma proteome. Nat Commun 8:14357. https:\/\/doi.org\/10.1038\/ncomms14357","journal-title":"Nat Commun"},{"key":"7280_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05512-x","volume":"9","author":"C Yao","year":"2018","unstructured":"Yao C, Chen G, Song C et al (2018) Genome\u2010wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease. Nat Commun 9:3268. https:\/\/doi.org\/10.1038\/s41467-018-05512-x","journal-title":"Nat Commun"},{"key":"7280_CR27","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41588-025-02089-2","volume":"57","author":"L Niu","year":"2025","unstructured":"Niu L, Stinson SE, Holm LA et al (2025) Plasma proteome variation and its genetic determinants in children and adolescents. Nat Genet 57:635\u2013646. https:\/\/doi.org\/10.1038\/s41588-025-02089-2","journal-title":"Nat Genet"},{"key":"7280_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","volume":"558","author":"BB Sun","year":"2018","unstructured":"Sun BB, Maranville JC, Peters JE et al (2018) Genomic atlas of the human plasma proteome. Nature 558:73\u201379. https:\/\/doi.org\/10.1038\/s41586-018-0175-2","journal-title":"Nature"},{"key":"7280_CR29","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1681\/ASN.2018101054","volume":"30","author":"S Dufek","year":"2019","unstructured":"Dufek S, Cheshire C, Levine AP et al (2019) Genetic identification of two novel loci associated with steroid-sensitive nephrotic syndrome. J Am Soc Nephrol 30:1375\u20131384. https:\/\/doi.org\/10.1681\/ASN.2018101054","journal-title":"J Am Soc Nephrol"},{"key":"7280_CR30","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/acr2.11404","volume":"4","author":"SLN Clarke","year":"2022","unstructured":"Clarke SLN, Richmond RC, Zheng J et al (2022) Examining health outcomes in juvenile idiopathic arthritis: a genetic epidemiology study. ACR Open Rheumatol 4:363\u2013370. https:\/\/doi.org\/10.1002\/acr2.11404","journal-title":"ACR Open Rheumatol"},{"key":"7280_CR31","doi-asserted-by":"crossref","unstructured":"Hemani G, Elsworth B, Palmer T, Rasteiro R (2025) ieugwasr: Interface to the \u201cOpenGWAS\u201d Database API. https:\/\/github.com\/MRCIEU\/ieugwasr. Accessed 14 Sept 2025","DOI":"10.32614\/CRAN.package.ieugwasr"},{"key":"7280_CR32","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"Auton A, Abecasis GR, Altshuler DM et al (2015) A global reference for human genetic variation. Nature 526:68\u201374. https:\/\/doi.org\/10.1038\/nature15393","journal-title":"Nature"},{"key":"7280_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.00157","volume":"11","author":"TA Myers","year":"2020","unstructured":"Myers TA, Chanock SJ, Machiela MJ (2020) LDlinkR: an R package for rapidly calculating linkage disequilibrium statistics in diverse populations. Front Genet 11:157. https:\/\/doi.org\/10.3389\/fgene.2020.00157","journal-title":"Front Genet"},{"key":"7280_CR34","doi-asserted-by":"publisher","first-page":"D977","DOI":"10.1093\/nar\/gkac1010","volume":"51","author":"E Sollis","year":"2023","unstructured":"Sollis E, Mosaku A, Abid A et al (2023) The NHGRI-EBI GWAS Catalog: knowledgebase and deposition resource. Nucleic Acids Res 51:D977\u2013D985. https:\/\/doi.org\/10.1093\/nar\/gkac1010","journal-title":"Nucleic Acids Res"},{"key":"7280_CR35","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41588-020-0622-5","volume":"52","author":"SA Gagliano Taliun","year":"2020","unstructured":"Gagliano Taliun SA, VandeHaar P, Boughton AP et al (2020) Exploring and visualizing large-scale genetic associations by using PheWeb. Nat Genet 52:550\u2013552. https:\/\/doi.org\/10.1038\/s41588-020-0622-5","journal-title":"Nat Genet"},{"key":"7280_CR36","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B et al (2018) The MR-Base platform supports systematic causal inference across the human phenome. Elife 7:e34408. https:\/\/doi.org\/10.7554\/eLife.34408","journal-title":"Elife"},{"key":"7280_CR37","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.15555.3","volume":"4","author":"S Burgess","year":"2019","unstructured":"Burgess S, Davey Smith G, Davies NM et al (2019) Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res 4:186. https:\/\/doi.org\/10.12688\/wellcomeopenres.15555.3","journal-title":"Wellcome Open Res"},{"key":"7280_CR38","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale J, Thomas J, Salvatore M et al (2013) The genotype-tissue expression (GTEx) project. Nat Genet 45:580\u2013585. https:\/\/doi.org\/10.1038\/ng.2653","journal-title":"Nat Genet"},{"key":"7280_CR39","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1126\/science.aat5031","volume":"365","author":"BJ Stewart","year":"2019","unstructured":"Stewart BJ, Ferdinand JR, Young MD et al (2019) Spatiotemporal immune zonation of the human kidney. Science 365:1461\u20131466. https:\/\/doi.org\/10.1126\/science.aat5031","journal-title":"Science"},{"key":"7280_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1009440","volume":"17","author":"C Wallace","year":"2021","unstructured":"Wallace C (2021) A more accurate method for colocalisation analysis allowing for multiple causal variants. PLoS Genet 17:e1009440. https:\/\/doi.org\/10.1371\/journal.pgen.1009440","journal-title":"PLoS Genet"},{"key":"7280_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE et al (2014) Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet 10:e1004383. https:\/\/doi.org\/10.1371\/journal.pgen.1004383","journal-title":"PLoS Genet"},{"key":"7280_CR42","doi-asserted-by":"publisher","unstructured":"Butler-Laporte G, Lu T, Morris S et al (2024) An accurate genetic colocalization method for the HLA locus. medRxiv. https:\/\/doi.org\/10.1101\/2024.11.05.24316783","DOI":"10.1101\/2024.11.05.24316783"},{"key":"7280_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50583-8","volume":"15","author":"C Krishna","year":"2024","unstructured":"Krishna C, Chiou J, Sakaue S et al (2024) The influence of HLA genetic variation on plasma protein expression. Nat Commun 15:6469. https:\/\/doi.org\/10.1038\/s41467-024-50583-8","journal-title":"Nat Commun"},{"key":"7280_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064683","volume":"8","author":"X Jia","year":"2013","unstructured":"Jia X, Han B, Onengut-Gumuscu S et al (2013) Imputing amino acid polymorphisms in human leukocyte antigens. PLoS One 8:e64683. https:\/\/doi.org\/10.1371\/journal.pone.0064683","journal-title":"PLoS One"},{"key":"7280_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj6367","volume":"9","author":"JB Nilsson","year":"2023","unstructured":"Nilsson JB, Kaabinejadian S, Yari H et al (2023) Accurate prediction of HLA class II antigen presentation across all loci using tailored data acquisition and refined machine learning. Sci Adv 9:eadj6367. https:\/\/doi.org\/10.1126\/sciadv.adj6367","journal-title":"Sci Adv"},{"key":"7280_CR46","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/ije\/dyt179","volume":"42","author":"M-JA Brion","year":"2013","unstructured":"Brion M-JA, Shakhbazov K, Visscher PM (2013) Calculating statistical power in Mendelian randomization studies. Int J Epidemiol 42:1497\u20131501. https:\/\/doi.org\/10.1093\/ije\/dyt179","journal-title":"Int J Epidemiol"},{"key":"7280_CR47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41576-020-0268-2","volume":"22","author":"K Suhre","year":"2021","unstructured":"Suhre K, McCarthy MI, Schwenk JM (2021) Genetics meets proteomics: perspectives for large population-based studies. Nat Rev Genet 22:19\u201337. https:\/\/doi.org\/10.1038\/s41576-020-0268-2","journal-title":"Nat Rev Genet"},{"key":"7280_CR48","doi-asserted-by":"publisher","first-page":"D948","DOI":"10.1093\/nar\/gkae1071","volume":"53","author":"SC Dyer","year":"2025","unstructured":"Dyer SC, Austine-Orimoloye O, Azov AG et al (2025) Ensembl 2025. Nucleic Acids Res 53:D948\u2013D957. https:\/\/doi.org\/10.1093\/nar\/gkae1071","journal-title":"Nucleic Acids Res"},{"key":"7280_CR49","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1210\/clinem\/dgac724","volume":"108","author":"M Adi","year":"2023","unstructured":"Adi M, Ghanbari F, Downie ML et al (2023) Effects of 25-hydroxyvitamin D levels on renal function: a bidirectional mendelian randomization study. J Clin Endocrinol Metab 108:1442\u20131451. https:\/\/doi.org\/10.1210\/clinem\/dgac724","journal-title":"J Clin Endocrinol Metab"},{"key":"7280_CR50","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/09680519050110020501","volume":"11","author":"JFP Berbee","year":"2005","unstructured":"Berbee JFP, Havekes LM, Rensen PCN (2005) Apolipoproteins modulate the inflammatory response to lipopolysaccharide. J Endotoxin Res 11:97\u2013103. https:\/\/doi.org\/10.1177\/09680519050110020501","journal-title":"J Endotoxin Res"},{"key":"7280_CR51","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2013.13781","volume":"143","author":"N Vuilleumier","year":"2013","unstructured":"Vuilleumier N, Dayer J-M, von Eckardstein A, Roux-Lombard P (2013) Pro- or anti-inflammatory role of apolipoprotein A-1 in high-density lipoproteins? Swiss Med Wkly 143:w13781. https:\/\/doi.org\/10.4414\/smw.2013.13781","journal-title":"Swiss Med Wkly"},{"key":"7280_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-016-0384-3","volume":"15","author":"T Shen","year":"2016","unstructured":"Shen T, Wu WM, Du WH et al (2016) Positive association between serum apolipoprotein M levels and hepatitis B virus DNA load in HBeAg-negative chronic hepatitis B. Lipids Health Dis 15:210. https:\/\/doi.org\/10.1186\/s12944-016-0384-3","journal-title":"Lipids Health Dis"},{"key":"7280_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005146","volume":"4","author":"L Jia","year":"2009","unstructured":"Jia L, Zhang L, Shao C et al (2009) An attempt to understand kidney\u2019s protein handling function by comparing plasma and urine proteomes. PLoS One 4:e5146. https:\/\/doi.org\/10.1371\/journal.pone.0005146","journal-title":"PLoS One"},{"key":"7280_CR54","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.devcel.2020.05.024","volume":"53","author":"B-S Ding","year":"2020","unstructured":"Ding B-S, Yang D, Swendeman SL et al (2020) Aging suppresses sphingosine-1-phosphate chaperone ApoM in circulation resulting in maladaptive organ repair. Dev Cell 53:677-690.e4. https:\/\/doi.org\/10.1016\/j.devcel.2020.05.024","journal-title":"Dev Cell"},{"key":"7280_CR55","doi-asserted-by":"publisher","first-page":"5181","DOI":"10.1096\/fj.201801748R","volume":"33","author":"M Kurano","year":"2019","unstructured":"Kurano M, Tsuneyama K, Morimoto Y et al (2019) Apolipoprotein M suppresses the phenotypes of IgA nephropathy in hyper-IgA mice. FASEB J 33:5181\u20135195. https:\/\/doi.org\/10.1096\/fj.201801748R","journal-title":"FASEB J"},{"key":"7280_CR56","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.ekir.2023.01.031","volume":"8","author":"Y Drexler","year":"2023","unstructured":"Drexler Y, Molina J, Elfassy T et al (2023) Identification of glomerular and plasma apolipoprotein M as novel biomarkers in glomerular disease. Kidney Int Rep 8:884\u2013897. https:\/\/doi.org\/10.1016\/j.ekir.2023.01.031","journal-title":"Kidney Int Rep"},{"key":"7280_CR57","doi-asserted-by":"publisher","first-page":"31286","DOI":"10.1074\/jbc.274.44.31286","volume":"274","author":"N Xu","year":"1999","unstructured":"Xu N, Dahlb\u00e4ck B (1999) A novel human apolipoprotein (apoM). J Biol Chem 274:31286\u201331290. https:\/\/doi.org\/10.1074\/jbc.274.44.31286","journal-title":"J Biol Chem"},{"key":"7280_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.754490","volume":"8","author":"LS Bisgaard","year":"2021","unstructured":"Bisgaard LS, Christoffersen C (2021) The apoM\/S1P complex-a mediator in kidney biology and disease? Front Med (Lausanne) 8:754490. https:\/\/doi.org\/10.3389\/fmed.2021.754490","journal-title":"Front Med (Lausanne)"},{"key":"7280_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113217","volume":"10","author":"S Chatzikonstantinou","year":"2021","unstructured":"Chatzikonstantinou S, Poulidou V, Arnaoutoglou M et al (2021) Signaling through the S1P-S1PR axis in the gut, the immune and the central nervous system in multiple sclerosis: implication for pathogenesis and treatment. Cells 10:3217. https:\/\/doi.org\/10.3390\/cells10113217","journal-title":"Cells"},{"key":"7280_CR60","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/cmi.2017.110","volume":"15","author":"M P\u00e9r\u00e8s","year":"2018","unstructured":"P\u00e9r\u00e8s M, Montfort A, Andrieu-Abadie N et al (2018) S1P: the elixir of life for naive T cells. Cell Mol Immunol 15:657\u2013659. https:\/\/doi.org\/10.1038\/cmi.2017.110","journal-title":"Cell Mol Immunol"},{"key":"7280_CR61","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41586-021-03227-6","volume":"592","author":"A Baeyens","year":"2021","unstructured":"Baeyens A, Bracero S, Chaluvadi VS et al (2021) Monocyte-derived S1P in the lymph node regulates immune responses. Nature 592:290\u2013295. https:\/\/doi.org\/10.1038\/s41586-021-03227-6","journal-title":"Nature"},{"key":"7280_CR62","doi-asserted-by":"publisher","first-page":"922","DOI":"10.17305\/bb.2023.9082","volume":"23","author":"J Li","year":"2023","unstructured":"Li J, Huang Y, Zhang Y et al (2023) S1P\/S1PR signaling pathway advancements in autoimmune diseases. Biomol Biomed 23:922\u2013935. https:\/\/doi.org\/10.17305\/bb.2023.9082","journal-title":"Biomol Biomed"},{"key":"7280_CR63","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000003770","author":"LA Giancotti","year":"2025","unstructured":"Giancotti LA, Squillace S, Chen Z et al (2025) Ozanimod, a functional sphingosine-1-phosphate receptor 1 antagonist, restores brainstem descending pain pathways in murine models of neuropathic pain. Pain. https:\/\/doi.org\/10.1097\/j.pain.0000000000003770","journal-title":"Pain"},{"key":"7280_CR64","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jns.2013.02.011","volume":"328","author":"A Groves","year":"2013","unstructured":"Groves A, Kihara Y, Chun J (2013) Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy. J Neurol Sci 328:9\u201318. https:\/\/doi.org\/10.1016\/j.jns.2013.02.011","journal-title":"J Neurol Sci"},{"key":"7280_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.892097","volume":"13","author":"JV Selkirk","year":"2022","unstructured":"Selkirk JV, Bortolato A, Yan YG et al (2022) Competitive binding of ozanimod and other sphingosine 1-phosphate receptor modulators at receptor subtypes 1 and 5. Front Pharmacol 13:892097. https:\/\/doi.org\/10.3389\/fphar.2022.892097","journal-title":"Front Pharmacol"},{"key":"7280_CR66","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1056\/NEJMoa0909494","volume":"362","author":"L Kappos","year":"2010","unstructured":"Kappos L, Radue E-W, O\u2019Connor P et al (2010) A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 362:387\u2013401. https:\/\/doi.org\/10.1056\/NEJMoa0909494","journal-title":"N Engl J Med"},{"key":"7280_CR67","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S1474-4422(19)30239-X","volume":"18","author":"G Comi","year":"2019","unstructured":"Comi G, Kappos L, Selmaj KW et al (2019) Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial. Lancet Neurol 18:1009\u20131020. https:\/\/doi.org\/10.1016\/S1474-4422(19)30239-X","journal-title":"Lancet Neurol"},{"key":"7280_CR68","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4103\/0976-500X.77118","volume":"2","author":"S Sharma","year":"2011","unstructured":"Sharma S, Mathur AG, Pradhan S et al (2011) Fingolimod (FTY720): First approved oral therapy for multiple sclerosis. J Pharmacol Pharmacother 2:49\u201351. https:\/\/doi.org\/10.4103\/0976-500X.77118","journal-title":"J Pharmacol Pharmacother"},{"key":"7280_CR69","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/ajmg.c.30071","volume":"139C","author":"J Bristow","year":"2005","unstructured":"Bristow J, Carey W, Egging D, Schalkwijk J (2005) Tenascin-X, collagen, elastin, and the Ehlers-Danlos syndrome. Am J Med Genet C Semin Med Genet 139C:24\u201330. https:\/\/doi.org\/10.1002\/ajmg.c.30071","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"7280_CR70","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1083\/jcb.125.2.483","volume":"125","author":"K Matsumoto","year":"1994","unstructured":"Matsumoto K, Saga Y, Ikemura T et al (1994) The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C. J Cell Biol 125:483\u2013493. https:\/\/doi.org\/10.1083\/jcb.125.2.483","journal-title":"J Cell Biol"},{"key":"7280_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1107787","volume":"14","author":"E Okuda-Ashitaka","year":"2023","unstructured":"Okuda-Ashitaka E, Matsumoto K (2023) Tenascin-X as a causal gene for classical-like Ehlers-Danlos syndrome. Front Genet 14:1107787. https:\/\/doi.org\/10.3389\/fgene.2023.1107787","journal-title":"Front Genet"},{"key":"7280_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1322395","volume":"15","author":"L Liang","year":"2024","unstructured":"Liang L, Wu H, Meng H et al (2024) Case report: A novel compound heterozygous variant in the TNXB gene causes single kidney agenesis and vesicoureteral reflux. Front Endocrinol (Lausanne) 15:1322395. https:\/\/doi.org\/10.3389\/fendo.2024.1322395","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7280_CR73","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1681\/ASN.2012121148","volume":"24","author":"RA Gbadegesin","year":"2013","unstructured":"Gbadegesin RA, Brophy PD, Adeyemo A et al (2013) TNXB mutations can cause vesicoureteral reflux. J Am Soc Nephrol 24:1313\u20131322. https:\/\/doi.org\/10.1681\/ASN.2012121148","journal-title":"J Am Soc Nephrol"},{"key":"7280_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113611","volume":"43","author":"D Noce","year":"2024","unstructured":"Noce D, Foco L, Orth-H\u00f6ller D et al (2024) Genetic determinants of complement activation in the general population. Cell Rep 43:113611. https:\/\/doi.org\/10.1016\/j.celrep.2023.113611","journal-title":"Cell Rep"},{"key":"7280_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37985-w","volume":"14","author":"A Barry","year":"2023","unstructured":"Barry A, McNulty MT, Jia X et al (2023) Multi-population genome-wide association study implicates immune and non-immune factors in pediatric steroid-sensitive nephrotic syndrome. Nat Commun 14:2481. https:\/\/doi.org\/10.1038\/s41467-023-37985-w","journal-title":"Nat Commun"},{"key":"7280_CR76","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.ekir.2023.05.018","volume":"8","author":"ML Downie","year":"2023","unstructured":"Downie ML, Gupta S, Voinescu C et al (2023) Common risk variants in AHI1 are associated with childhood steroid sensitive nephrotic syndrome. Kidney Int Rep 8:1562\u20131574. https:\/\/doi.org\/10.1016\/j.ekir.2023.05.018","journal-title":"Kidney Int Rep"},{"key":"7280_CR77","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.kint.2020.05.029","volume":"98","author":"X Jia","year":"2020","unstructured":"Jia X, Yamamura T, Gbadegesin R et al (2020) Common risk variants in NPHS1 and TNFSF15 are associated with childhood steroid-sensitive nephrotic syndrome. Kidney Int 98:1308\u20131322. https:\/\/doi.org\/10.1016\/j.kint.2020.05.029","journal-title":"Kidney Int"},{"key":"7280_CR78","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1681\/ASN.2017111185","volume":"29","author":"H Debiec","year":"2018","unstructured":"Debiec H, Dossier C, Letouz\u00e9 E et al (2018) Transethnic, genome-wide analysis reveals immune-related risk alleles and phenotypic correlates in pediatric steroid-sensitive nephrotic syndrome. J Am Soc Nephrol 29:2000\u20132013. https:\/\/doi.org\/10.1681\/ASN.2017111185","journal-title":"J Am Soc Nephrol"},{"key":"7280_CR79","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1007\/s00467-022-05789-7","volume":"38","author":"ML Downie","year":"2023","unstructured":"Downie ML, Gupta S, Chan MMY et al (2023) Shared genetic risk across different presentations of gene test\u2013negative idiopathic nephrotic syndrome. Pediatr Nephrol 38:1793\u20131800. https:\/\/doi.org\/10.1007\/s00467-022-05789-7","journal-title":"Pediatr Nephrol"},{"key":"7280_CR80","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1074\/mcp.M116.066720","volume":"16","author":"S Bjelosevic","year":"2017","unstructured":"Bjelosevic S, Pascovici D, Ping H et al (2017) Quantitative age-specific variability of plasma proteins in healthy neonates, children and adults. Mol Cell Proteomics 16:924\u2013935. https:\/\/doi.org\/10.1074\/mcp.M116.066720","journal-title":"Mol Cell Proteomics"},{"key":"7280_CR81","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1038\/s41591-019-0673-2","volume":"25","author":"B Lehallier","year":"2019","unstructured":"Lehallier B, Gate D, Schaum N et al (2019) Undulating changes in human plasma proteome profiles across the lifespan. Nat Med 25:1843\u20131850. https:\/\/doi.org\/10.1038\/s41591-019-0673-2","journal-title":"Nat Med"},{"key":"7280_CR82","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00467-018-4119-8","volume":"34","author":"T Korsgaard","year":"2019","unstructured":"Korsgaard T, Andersen RF, Joshi S et al (2019) Childhood onset steroid-sensitive nephrotic syndrome continues into adulthood. Pediatr Nephrol 34:641\u2013648. https:\/\/doi.org\/10.1007\/s00467-018-4119-8","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07280-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-026-07280-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07280-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:06:24Z","timestamp":1785452784000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-026-07280-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":82,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["7280"],"URL":"https:\/\/doi.org\/10.1007\/s00467-026-07280-z","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This manuscript is available on a pre-print server at\u00a0","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was not required for this study as we used publicly available de-identified datasets. Ethics approvals and informed participant consents were obtained for each of the GWAS studies described in Supplementary Table\n                      \n                      .","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}